Aesthetic and dermatology economics depend on courses, packages and repeat attendance. Drapto measures revenue per treatment and device, tracks package balances, and surfaces the lapsed patients most likely to return.
Acquisition is expensive. Reactivation is nearly free.
Most aesthetic clinics spend heavily to win new patients while several years of lapsed clients sit uncontacted in the database — people who already know the clinic and already trusted it once.
Injectables, laser, surgical and skincare each behave differently, and device-based treatments carry capital cost that must be earned back. Reporting revenue at treatment level shows what actually pays for the equipment.
The Patient Reactivation agent identifies dormant patients from your own visit history, segments them by value and how long they have lapsed, and drafts outreach for each segment — reviewed by your team before anything sends.
Break-even modelling before purchase and utilisation measurement afterwards turns capital spend into a checked assumption.
Visible package balances mean fewer patients quietly stop halfway through a paid course.
Cost per acquired patient by campaign reorders which channels deserve budget.
Systematic reactivation reaches people who already trust the clinic, at a fraction of acquisition cost.
Yes. Package and course balances are tracked, with outstanding amounts aged like any other balance.
No. It identifies dormant patients, segments them and drafts the outreach. Your team reviews and approves before anything sends.
Yes, using the free break-even calculator, which models contribution, break-even volume and payback with a ramp period.
Yes. All three agents run on your own AI provider key and work from data already in your account. The Revenue Leakage Analyst calculates deterministically, so every figure it reports is verifiable against your own books.